Home Other Building Blocks 125559-00-4
125559-00-4,MFCD01863459
Catalog No.:AA000NSO

125559-00-4 | Lc-smcc

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
≥ 98% (Assay)
in stock  
$221.00   $155.00
- +
100mg
≥ 98% (Assay)
in stock  
$398.00   $278.00
- +
250mg
≥ 98% (Assay)
in stock  
$706.00   $494.00
- +
1g
≥ 98% (Assay)
in stock  
$2,047.00   $1,433.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000NSO
Chemical Name:
Lc-smcc
CAS Number:
125559-00-4
Molecular Formula:
C22H29N3O7
Molecular Weight:
447.4816
MDL Number:
MFCD01863459
SMILES:
O=C(ON1C(=O)CCC1=O)CCCCCNC(=O)C1CCC(CC1)CN1C(=O)C=CC1=O
Properties
Computed Properties
 
Complexity:
780  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
32  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
11  
XLogP3:
0.2  

Downstream Synthesis Route
tranexamicacid 
  125559-00-4    951792-85-1 

[1]CurrentPatentAssignee:DRAISPHARMACEUTICALS-WO2007/113687,2007,A2Locationinpatent:Page/Pagecolumn45

125559-00-4    1020412-43-4   
1-4-({6-({7-amino-3-(2-hydroxy-2-methylpropyl)-3.5.8-triazatricyclo7.4.0.02,6trideca-1(9),2(6),4,7,10,12-hexaen-4-yl}methyl)-N-ethylamino-6-oxohexylamino}carbonyl)cyclohexylmethyl}-1H-pyrrole-2,5-dione 

[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/140831,2018,A2Locationinpatent:Paragraph0638;0639

125559-00-4   
C29H38N6O4 
 
2-amino-N8-(5-((6-(4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamido)hexanamido)methyl)pyridin-3-yl)-N4,N4-dipropyl-3H-benzobazepine-4,8-dicarboxamide 

[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-US2018/258048,2018,A1Locationinpatent:Paragraph0605-0607

125559-00-4   
(S)-2-amino-N<SUP>1</SUP>-(4-(5-amino-6-((4-morpholinopyridin-3-yl)carbamoyl)pyrazin-2-yl)benzyl)-N<SUP>5</SUP>-(2-(3-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-3-oxopropoxy)ethyl)pentanediamidetrihydrochloride 
 
(S)-N1-(4-(5-amino-6-((4-morpholinopyridin-3-yl)carbamoyl)pyrazin-2-yl)benzyl)-2-(6-(4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)-cyclohexane-1-carboxamido)hexanamido)-N5-(2-(3-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-3-oxopropoxy)ethyl)pentanediamide 

[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227018,2018,A1Locationinpatent:Paragraph00385;00393

[2]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227023,2018,A1Locationinpatent:Paragraph0612

125559-00-4   
C44H49N11O8*3ClH 
 
3-amino-6-(4-(2-((2S)-2-(6-(4-((2,5-dioxo-2,5-diliydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamido)hexanamido)-6-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)hexanamido)ethyl)phenyl)-N-(4-morpholinopyridin-3-yl)pyrazine-2-carboxamide 

[1]CurrentPatentAssignee:SILVERBACKTHERAPEUTICSINC-WO2018/227018,2018,A1Locationinpatent:Paragraph00395;00401

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:125559-00-4 Molecular Formula|125559-00-4 MDL|125559-00-4 SMILES|125559-00-4 Lc-smcc